TNF and retinitis pigmentosa 1: The results obtained in the present study revealed that intraperitoneal administration of Adalimumab, a recombinant human monoclonal antibody against TNFα, reduced retinal degeneration decreasing photoreceptor cell death and reactive gliosis at early stages of RP in rd10 mice.